12/2
03:41 pm
ebs
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/30
03:33 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
Medium
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
11/26
02:06 pm
ebs
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
08:00 am
ebs
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
Low
Report
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
11/12
04:27 pm
ebs
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors [Yahoo! Finance]
Low
Report
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors [Yahoo! Finance]
11/12
04:01 pm
ebs
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
Medium
Report
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
11/11
02:00 pm
ebs
PDA Releases Three New Foundational Documents to Advance Aseptic Processing and Sterilizing Filtration Practices
Low
Report
PDA Releases Three New Foundational Documents to Advance Aseptic Processing and Sterilizing Filtration Practices
11/9
01:13 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
Medium
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
11/1
01:04 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
High
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
10/29
04:15 pm
ebs
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
High
Report
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
10/28
08:00 am
ebs
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
Medium
Report
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
10/28
06:18 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Zacks Research to a "hold" rating.
10/24
12:21 pm
ebs
Emergent Biosolutions (NYSE:EBS) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Emergent Biosolutions (NYSE:EBS) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
10/8
07:45 am
ebs
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
Low
Report
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
10/1
05:02 am
ebs
Prefilled Syringe Fill Finish Manufacturing Research Report 2025-2035: 100+ Providers Identified as Catalent, AMRI, Sandoz and Pierre Fabre Lead Clinical and Commercial Operations [Yahoo! Finance]
Low
Report
Prefilled Syringe Fill Finish Manufacturing Research Report 2025-2035: 100+ Providers Identified as Catalent, AMRI, Sandoz and Pierre Fabre Lead Clinical and Commercial Operations [Yahoo! Finance]
9/24
05:23 pm
ebs
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone [Yahoo! Finance]
Medium
Report
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone [Yahoo! Finance]
9/24
04:05 pm
ebs
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
Medium
Report
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
9/23
12:14 pm
ebs
Lyophilization Services Market Industry Trends and Forecasts 2025-2035: Global Lyophilization Services Market to Double by 2035 [Yahoo! Finance]
Low
Report
Lyophilization Services Market Industry Trends and Forecasts 2025-2035: Global Lyophilization Services Market to Double by 2035 [Yahoo! Finance]
9/23
10:07 am
ebs
Antibody Contract Manufacturing Market Industry Trends and Global Forecast Report 2025-2035 | Monoclonal Antibodies Dominate Market, But Bispecific Antibodies Gain Traction [Yahoo! Finance]
Medium
Report
Antibody Contract Manufacturing Market Industry Trends and Global Forecast Report 2025-2035 | Monoclonal Antibodies Dominate Market, But Bispecific Antibodies Gain Traction [Yahoo! Finance]
9/19
09:07 am
ebs
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner [Yahoo! Finance]
Low
Report
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner [Yahoo! Finance]
9/19
08:34 am
ebs
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
Medium
Report
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
9/15
08:56 am
ebs
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain [Yahoo! Finance]
Neutral
Report
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain [Yahoo! Finance]
9/15
08:35 am
ebs
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
Low
Report
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
9/12
05:48 pm
ebs
The National Institute of Biomedical Research and Ridgeback Biotherapeutics Respond to 16th Ebola Outbreak in the Democratic Republic of Congo [Yahoo! Finance]
Low
Report
The National Institute of Biomedical Research and Ridgeback Biotherapeutics Respond to 16th Ebola Outbreak in the Democratic Republic of Congo [Yahoo! Finance]
9/9
12:35 pm
ebs
US Government signs $56m smallpox/mpox vaccine order despite political disarray [Yahoo! Finance]
Low
Report
US Government signs $56m smallpox/mpox vaccine order despite political disarray [Yahoo! Finance]